Pro Medicus Limited (ASX:PME)
162.24
+2.42 (1.51%)
Jul 27, 2026, 4:10 PM AEST
Pro Medicus Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Pro Medicus stock has a consensus rating of "Buy" and an average price target of $190.68. The average 1-year stock price forecast is 17.53% higher than the current stock price, while the lowest is $54.00 (-66.72%) and the highest is $250.00 (+54.09%).
Price Target: $190.68 (+17.53%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Pro Medicus stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 7 | 9 | 9 | 7 |
| Buy | 2 | 2 | 3 | 3 | 3 | 4 |
| Hold | 4 | 3 | 3 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 13 | 13 | 14 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $240.00 | Buy | Maintains | $240.00 | +47.93% | Jul 15, 2026 |
| Morgans | Morgans | Buy Maintains $210.00 → $230.00 | Buy | Maintains | $210.00 → $230.00 | +41.77% | Jul 14, 2026 |
| Jefferies | Jefferies | Hold Downgrades $192.60 | Hold | Downgrades | $192.60 | +18.71% | Jul 13, 2026 |
Unknown Analyst Macquarie No rating | Macquarie | Buy Maintains $221.00 | Buy | Maintains | $221.00 | +36.22% | Jun 2, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $195.00 | Hold | Maintains | $195.00 | +20.19% | Jun 1, 2026 |
Financial Forecast
Revenue This Year
261.88M
from 212.98M
Increased by 22.96%
Revenue Next Year
335.08M
from 261.88M
Increased by 27.95%
EPS This Year
1.36
from 1.14
Increased by 19.71%
EPS Next Year
1.80
from 1.36
Increased by 31.94%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.